JEFFREY J. KRAWS is a Pharmaceutical Analyst at Gruntal & Company,
L.L.C., focusing on large cap pharmaceutical, specialty pharmaceutical,
drug delivery/distribution systems, biopharmaceutical and medical
technology stocks. He was previously associated with EVEREN Securities,
Bristol-Myers Squibb and Buckingham Research. Mr. Kraws received a BS
from the State University of New York and an MBA from Cornell
University.
Roundtable Forum: Pharmaceutical Industry
January 22, 2001
Roundtable Forum: Pharmaceutical Industry
January 24, 2000
Pharmaceutical Stocks : Jeffrey J. Kraws - Everen Securities
February 01, 1999